
ZhuZhou QianJin Pharmaceutical Co.,Ltd
SSE:600479.SS
10.7 (CNY) • At close June 6, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 3,629.804 | 3,798.485 | 4,026.279 | 3,663.845 | 3,626.967 | 3,525.238 | 3,328.554 | 3,182.744 | 2,864.886 | 2,446.684 | 2,194.24 | 1,972.855 | 1,583.423 | 1,256.527 | 979.444 | 904.27 | 801.429 | 679.777 | 602.686 | 665.826 | 604.928 | 686.8 | 582.027 | 560.212 |
Cost of Revenue
| 1,946.339 | 2,050.51 | 2,289.865 | 2,032.238 | 2,030.778 | 1,918.691 | 1,776.271 | 1,743.231 | 1,573.324 | 1,311.508 | 1,141.092 | 1,006.817 | 786.315 | 603.538 | 427.855 | 360.833 | 345.793 | 322.306 | 309.368 | 423.794 | 409.396 | 476.096 | 405.901 | 417.276 |
Gross Profit
| 1,683.466 | 1,747.975 | 1,736.413 | 1,631.606 | 1,596.189 | 1,606.547 | 1,552.283 | 1,439.513 | 1,291.562 | 1,135.176 | 1,053.149 | 966.038 | 797.108 | 652.989 | 551.589 | 543.437 | 455.637 | 357.471 | 293.318 | 242.032 | 195.532 | 210.704 | 176.126 | 142.936 |
Gross Profit Ratio
| 0.464 | 0.46 | 0.431 | 0.445 | 0.44 | 0.456 | 0.466 | 0.452 | 0.451 | 0.464 | 0.48 | 0.49 | 0.503 | 0.52 | 0.563 | 0.601 | 0.569 | 0.526 | 0.487 | 0.364 | 0.323 | 0.307 | 0.303 | 0.255 |
Reseach & Development Expenses
| 220.205 | 149.067 | 113.821 | 108.715 | 104.056 | 105.363 | 84.091 | 67.001 | 61.856 | 64.69 | 48.229 | 36.793 | 32.981 | 14.644 | 10.61 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 58.173 | 63.888 | 67.646 | 74.991 | 69.789 | 55.807 | 41.774 | 43.723 | 41.382 | 38.271 | 33.89 | 31.451 | 31.136 | 26.731 | 20.06 | 71.005 | 59.095 | 54.292 | 57.582 | 49.119 | 44.375 | 43.653 | 37.31 | 29.026 |
Selling & Marketing Expenses
| -326.026 | 889.221 | 911.583 | 888.298 | 894.856 | 938.862 | 994.172 | 942.519 | 861.899 | 801.827 | 724.883 | 624.389 | 508.755 | 428.56 | 379.736 | 321.076 | 275.445 | 221.325 | 173.988 | 124.441 | 98.614 | 94.7 | 77.727 | 61.07 |
SG&A
| -267.854 | 1,184.482 | 979.229 | 963.289 | 964.644 | 994.67 | 1,035.946 | 986.242 | 903.282 | 840.099 | 758.773 | 655.84 | 539.891 | 455.291 | 399.797 | 392.081 | 334.54 | 275.616 | 231.57 | 173.56 | 142.988 | 138.353 | 115.037 | 90.096 |
Other Expenses
| 1,399.004 | -47.514 | 218.606 | 189.115 | 156.084 | 147.753 | 14.911 | -9.71 | 13.562 | 14.952 | 10.549 | 3.716 | 0.726 | 1.605 | 8.09 | 1.657 | -1.127 | 0.133 | 1.238 | 1.309 | 1.755 | -0.801 | -0.939 | -1.961 |
Operating Expenses
| 1,351.355 | 1,289.817 | 1,311.657 | 1,261.119 | 1,224.784 | 1,247.785 | 1,249.118 | 1,170.893 | 1,111.651 | 1,042.92 | 924.326 | 810.394 | 663.733 | 536.536 | 473.971 | 404.502 | 345.252 | 282.897 | 237.686 | 178.007 | 146.338 | 142.323 | 118.096 | 92.851 |
Operating Income
| 332.111 | 461.94 | 444.247 | 436.232 | 424.179 | 430.776 | 337.392 | 296.35 | 193.951 | 94.755 | 130.415 | 149.985 | 150.89 | 108.085 | 101.533 | 155.238 | 143.055 | 198.891 | 83.881 | 74.271 | 55.256 | 71.465 | 60.225 | 51.902 |
Operating Income Ratio
| 0.091 | 0.122 | 0.11 | 0.119 | 0.117 | 0.122 | 0.101 | 0.093 | 0.068 | 0.039 | 0.059 | 0.076 | 0.095 | 0.086 | 0.104 | 0.172 | 0.178 | 0.293 | 0.139 | 0.112 | 0.091 | 0.104 | 0.103 | 0.093 |
Total Other Income Expenses Net
| 3.197 | -1.52 | 1.565 | -2.81 | 0.406 | -1.079 | 14.911 | -9.71 | 12.427 | 14.845 | 10.002 | 2.865 | 0.399 | 1.569 | 27.755 | 17.409 | 31.448 | 123.3 | 0.441 | 9.062 | 6.512 | -1.343 | -0.933 | -2.163 |
Income Before Tax
| 335.308 | 460.419 | 445.813 | 433.422 | 424.585 | 429.697 | 352.303 | 286.64 | 206.378 | 109.6 | 140.417 | 152.85 | 151.29 | 109.654 | 109.538 | 156.055 | 141.833 | 197.874 | 84.322 | 74.333 | 56.359 | 70.123 | 59.292 | 49.739 |
Income Before Tax Ratio
| 0.092 | 0.121 | 0.111 | 0.118 | 0.117 | 0.122 | 0.106 | 0.09 | 0.072 | 0.045 | 0.064 | 0.077 | 0.096 | 0.087 | 0.112 | 0.173 | 0.177 | 0.291 | 0.14 | 0.112 | 0.093 | 0.102 | 0.102 | 0.089 |
Income Tax Expense
| 32.699 | 65.403 | 57.55 | 58.682 | 64.378 | 77.598 | 49.747 | 39.982 | 33.017 | 21.262 | 22.721 | 24.067 | 20.384 | 14.882 | 11.957 | 19.145 | 7.345 | 21.279 | 9.361 | 12.614 | 9.779 | 21.689 | 20.346 | 14.392 |
Net Income
| 230.757 | 320.406 | 302.509 | 302.063 | 297.072 | 294.313 | 255.355 | 207.758 | 149.429 | 92.96 | 105.093 | 123.768 | 120.164 | 82.821 | 86.383 | 130.914 | 129.892 | 173.619 | 71.779 | 59.864 | 45.388 | 50.073 | 39.751 | 34.488 |
Net Income Ratio
| 0.064 | 0.084 | 0.075 | 0.082 | 0.082 | 0.083 | 0.077 | 0.065 | 0.052 | 0.038 | 0.048 | 0.063 | 0.076 | 0.066 | 0.088 | 0.145 | 0.162 | 0.255 | 0.119 | 0.09 | 0.075 | 0.073 | 0.068 | 0.062 |
EPS
| 0.56 | 0.76 | 0.73 | 0.72 | 0.71 | 0.7 | 0.61 | 0.5 | 0.36 | 0.24 | 0.29 | 0.34 | 0.33 | 0.23 | 0.24 | 0.36 | 0.36 | 0.47 | 0.3 | 0.14 | 0.11 | 0.18 | 0.13 | 0.11 |
EPS Diluted
| 0.56 | 0.76 | 0.73 | 0.72 | 0.71 | 0.7 | 0.61 | 0.5 | 0.36 | 0.24 | 0.29 | 0.34 | 0.33 | 0.23 | 0.24 | 0.36 | 0.36 | 0.47 | 0.3 | 0.14 | 0.11 | 0.18 | 0.13 | 0.11 |
EBITDA
| 436.07 | 580.547 | 568.281 | 541.072 | 504.28 | 501.37 | 420.893 | 356.223 | 263.988 | 169.315 | 198.12 | 205.252 | 197.604 | 148.123 | 150.016 | 165.101 | 132.151 | 95.485 | 109.636 | 97.806 | 79.532 | 90.706 | 73.436 | 50.016 |
EBITDA Ratio
| 0.12 | 0.153 | 0.141 | 0.148 | 0.139 | 0.142 | 0.126 | 0.112 | 0.092 | 0.069 | 0.09 | 0.104 | 0.125 | 0.118 | 0.153 | 0.183 | 0.165 | 0.14 | 0.182 | 0.147 | 0.131 | 0.132 | 0.126 | 0.089 |